Price Capital Management’s Insmed INSM Stock Holding History

Price Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-12,102	Closed	-$252K	–	114
2015 Q1	$252K	Buy	+12,102	New	+$213K	0.16%	139

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Price Capital Management's INSM Position: Q2 2015 in Review

Price Capital Management sold out of Insmed (INSM) in Q2 2015, closing a stake of 12,102 shares — an estimated $252K sold.

Price Capital Management first reported a position in INSM in Q1 2015 and held it in 1 quarter. The position peaked at $252K in Q1 2015. 116 funds tracked by Wall St. Rank hold INSM as of Q2 2015.

Price Capital Management reported no remaining Insmed position as of Q2 2015 after selling out during the quarter.
Price Capital Management sold 12,102 Insmed shares in Q2 2015, an estimated $252K.
Price Capital Management first reported a position in Insmed in Q1 2015 and held it in 1 quarter.
Price Capital Management's Insmed position peaked at $252K in Q1 2015.
116 funds tracked by Wall St. Rank held Insmed as of Q2 2015.

Based on Price Capital Management's 13F filing for Q2 2015.